SPOT MAS is a multi-cancer early detection test developed by Gene Solutions [Video]

Region’s largest clinical validation for multimodal analysis in plasma cell-free DNA to detect signal of circulating tumor DNA and predict tumor location. (*)

(*) L.S. Tran, “Clinical validation of a ctDNA-based assay for multi-cancer detection: An interim report from a Vietnamese longitudinal prospective cohort study of 2795 participants.” (ASCO Publications, JCO Global Oncology, 2023)

#genesolutions #spot-mas
🌐 https://genesolutions.com/our-test/spot-mas